Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-12

Clinical Trial Update: A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update describing a study of tirzepatide versus intensified conventional care in adults with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MOUNJARO (tirzepatide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes | Phase 4 | Status: ACTIVE_NOT_RECRUITING